These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15724793)

  • 1. Hypertension: trends, risks, drug therapies and clinical challenges in African Americans.
    Hollar D; Agatston AS; Hennekens CH
    Ethn Dis; 2004; 14(4):S2-23-5. PubMed ID: 15724793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of hypertension in African Americans.
    Ferdinand KC; Armani AM
    Crit Pathw Cardiol; 2007 Jun; 6(2):67-71. PubMed ID: 17667868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for angiotensin II receptor blockers in patients with low-renin hypertension.
    Jamerson KA
    Am J Kidney Dis; 2000 Sep; 36(3 Suppl 1):S24-30. PubMed ID: 10986156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for the management of special populations: racial and ethnic populations.
    Ferdinand KC
    Am J Hypertens; 2003 Nov; 16(11 Pt 2):50S-54S. PubMed ID: 14625162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal treatment of hypertension and cardiovascular risk reduction in African Americans: treatment approaches for outpatients.
    Wright JT; Douglas J
    J Clin Hypertens (Greenwich); 2003; 5(1 Suppl 1):18-25. PubMed ID: 12556669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal outcomes in hypertensive Black patients at high cardiovascular risk.
    Weir MR; Bakris GL; Weber MA; Dahlof B; Devereux RB; Kjeldsen SE; Pitt B; Wright JT; Kelly RY; Hua TA; Hester RA; Velazquez E; Jamerson KA
    Kidney Int; 2012 Mar; 81(6):568-76. PubMed ID: 22189843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension-related morbidity and mortality in African Americans--why we need to do better.
    Ferdinand KC; Saunders E
    J Clin Hypertens (Greenwich); 2006 Jan; 8(1 Suppl 1):21-30. PubMed ID: 16415637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
    Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
    JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.
    Wright JT; Dunn JK; Cutler JA; Davis BR; Cushman WC; Ford CE; Haywood LJ; Leenen FH; Margolis KL; Papademetriou V; Probstfield JL; Whelton PK; Habib GB;
    JAMA; 2005 Apr; 293(13):1595-608. PubMed ID: 15811979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition and Management of Hypertension in Older Persons: Focus on African Americans.
    Still CH; Ferdinand KC; Ogedegbe G; Wright JT
    J Am Geriatr Soc; 2015 Oct; 63(10):2130-8. PubMed ID: 26480975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review: antihypertensive drug therapy in patients of African and South Asian ethnicity.
    Brewster LM; van Montfrans GA; Oehlers GP; Seedat YK
    Intern Emerg Med; 2016 Apr; 11(3):355-74. PubMed ID: 27026378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should African Americans with hypertension be treated differently than non-African Americans?
    Flack JM; Ference BA; Levy P
    Curr Hypertens Rep; 2014 Jan; 16(1):409. PubMed ID: 24370966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Chen YJ; Li LJ; Tang WL; Song JY; Qiu R; Li Q; Xue H; Wright JM
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008170. PubMed ID: 30480768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating hypertension with cardioprotective therapies: the role of ACE inhibitors, ARBs, and beta-blockers.
    Staffileno BA
    J Cardiovasc Nurs; 2005; 20(5):354-64. PubMed ID: 16141781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-Gene Interactions of Antihypertensive Medications and Risk of Incident Cardiovascular Disease: A Pharmacogenomics Study from the CHARGE Consortium.
    Bis JC; Sitlani C; Irvin R; Avery CL; Smith AV; Sun F; Evans DS; Musani SK; Li X; Trompet S; Krijthe BP; Harris TB; Quibrera PM; Brody JA; Demissie S; Davis BR; Wiggins KL; Tranah GJ; Lange LA; Sotoodehnia N; Stott DJ; Franco OH; Launer LJ; Stürmer T; Taylor KD; Cupples LA; Eckfeldt JH; Smith NL; Liu Y; Wilson JG; Heckbert SR; Buckley BM; Ikram MA; Boerwinkle E; Chen YD; de Craen AJ; Uitterlinden AG; Rotter JI; Ford I; Hofman A; Sattar N; Slagboom PE; Westendorp RG; Gudnason V; Vasan RS; Lumley T; Cummings SR; Taylor HA; Post W; Jukema JW; Stricker BH; Whitsel EA; Psaty BM; Arnett D
    PLoS One; 2015; 10(10):e0140496. PubMed ID: 26516778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race and ethnicity in trials of antihypertensive therapy to prevent cardiovascular outcomes: a systematic review.
    Park IU; Taylor AL
    Ann Fam Med; 2007; 5(5):444-52. PubMed ID: 17893387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    JAMA; 2002 Dec; 288(23):2981-97. PubMed ID: 12479763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial.
    Norris K; Bourgoigne J; Gassman J; Hebert L; Middleton J; Phillips RA; Randall O; Rostand S; Sherer S; Toto RD; Wright JT; Wang X; Greene T; Appel LJ; Lewis J;
    Am J Kidney Dis; 2006 Nov; 48(5):739-51. PubMed ID: 17059993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of high-risk African American patients: left ventricular dysfunction, heart failure, renal disease, and postmyocardial infarction.
    Arora R; Clark L; Taylor M
    J Clin Hypertens (Greenwich); 2003; 5(1 Suppl 1):26-31. PubMed ID: 12556670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.